interventional
N/A
1 country
1
To prevent the development of chronic postoperative pain after inguinal hernia surgery and knee replacement surgery and to further explore the mechanism behind the development of chronic postoperative pain
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 9, 2024
Actual (reported)The effect of Tapentadol compared to placebo on the development of chronic pain in the first year after surgery in patients planned for elective inguinal hernia surgery and knee replacement surgery.
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Formulated product
PALEXIA Retard 50 mg tabletten met verlengde afgifte
The registry describes a specific formulation. Its exact chemical ingredients and approval status require separate evidence.
PROLONGED-RELEASE TABLET
View registry recordThe registry names these ingredients. The formulation’s exact chemical form has not been confirmed.
PALEXIA Retard 50 mg tabletten met verlengde afgifte
Named ingredient: Tapentadol hydrochloride
View registry recordRegistry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Reinier de Graaf Groep
Delft, 2625 AD, Netherlands
Monique van Velzen
First Submitted
July 9, 2024
Download the complete CTIS (EMA) record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: European Medicines Agency (EMA), Clinical Trials Information System (CTIS). Original record and public documents are available on CTIS.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Comparison of Postoperative Analgesia Between Intravenous Paracetamol and Intranasal Tapentadol
Contact the study team to confirm eligibility.